advisorsecurities master

QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares

CSNasdaq (XNAS)·USD

Identity

Security key
20654
Ticker
QNTM
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2018-06-07
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
QNTM

Detail

Enriched 2026-08-14 20:47

Market cap
$22,374,990.6
Shares outstanding (class)
3,816,937
Shares outstanding (weighted)
6,429,595
SIC
Employees
7
Location
Description

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data